Literature DB >> 27044634

SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer.

Pengnan Zhang1, Yanmei Liu2, Youji Feng3, Shujun Gao4.   

Abstract

The aim of this study was to investigate the relationship between HIF-1α and SNAIL gene expression in the epithelial ovarian cancer (EOC) cell line. EOC cells were treated with hypoxia, hypoxia combined with rapamycin, and control. The expression of HIF-1α and E-cad were assessed by reverse transcription-polymerase chain reaction (RT-PCR) and western blotting. The gene expression of SNAIL was studied by RT-PCR and real-time PCR. RNA interference technology was used to determine the relationship between HIF-1α and SNAIL. The present study indicated that the HIF-1α protein was expressed and increased in EOC cell line. SNAIL mRNA was found to increase and E-cad expression decreased with the time of hypoxia prolonged. Hypoxia increased invasion abilities of EOC cell line, but compared with cells exposed to hypoxia, the change of invasive ability of cells with rapamycin had no effect. The expression of HIF-1α protein and SNAIL mRNA could be inhibited gradually by rapamycin. siRNA of HIF-1α could suppress the expression of SNAIL while siRNA of SNAIL had no influence on HIF-1α protein expression. HIF-1α may be the upstream of the SNAIL gene in EOC. Our data suggested that HIF-1α might be an upregulator of the SNAIL gene and HIF-1α-SNAIL-E-cad pathway may play an important role in EOC invasion and metastasis.
© The Author(s) 2016.

Entities:  

Keywords:  SNAIL gene; epithelial ovarian cancer; hypoxia-inducible factor 1α

Mesh:

Substances:

Year:  2016        PMID: 27044634      PMCID: PMC5806747          DOI: 10.1177/0394632016641423

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  33 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Twist: a new link from hypoxia to fibrosis.

Authors:  Wibke Bechtel; Michael Zeisberg
Journal:  Kidney Int       Date:  2009-06       Impact factor: 10.612

4.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

5.  Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

Authors:  M M Vleugel; A E Greijer; A Shvarts; P van der Groep; M van Berkel; Y Aarbodem; H van Tinteren; A L Harris; P J van Diest; E van der Wall
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

6.  Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.

Authors:  Vaishali Pansare; Adnan R Munkarah; Veronica Schimp; M Haitham Arabi; Ghassan M Saed; Robert T Morris; Rouba Ali-Fehmi
Journal:  Mod Pathol       Date:  2006-11-10       Impact factor: 7.842

Review 7.  New anticancer strategies targeting HIF-1.

Authors:  Eun-Jin Yeo; Yang-Sook Chun; Jong-Wan Park
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

8.  Transcriptional repressor snail and progression of human hepatocellular carcinoma.

Authors:  Keishi Sugimachi; Shinji Tanaka; Toshifumi Kameyama; Ken-ichi Taguchi; Shin-ichi Aishima; Mitsuo Shimada; Keizo Sugimachi; Masazumi Tsuneyoshi
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

9.  Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.

Authors:  Tsutomu Imai; Akiko Horiuchi; Cuiju Wang; Kenji Oka; Satoshi Ohira; Toshio Nikaido; Ikuo Konishi
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.

Authors:  Muh-Hwa Yang; Kou-Juey Wu
Journal:  Cell Cycle       Date:  2008-05-21       Impact factor: 4.534

View more
  5 in total

Review 1.  Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis.

Authors:  Calen A Steiner; Ian M Cartwright; Cormac T Taylor; Sean P Colgan
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

2.  Anticancer Activity of Modified Tongyou Decoction on Eca109 Esophageal Cancer Cell Invasion and Metastasis through Regulation of the Epithelial-Mesenchymal Transition Mediated by the HIF-1α-Snail Axis.

Authors:  Yongsen Jia; Xin Yan; Ying Cao; Wei Song; Guangji Zhang; Xueqin Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-29       Impact factor: 2.629

Review 3.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

Review 4.  Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.

Authors:  Vitor Rodrigues da Costa; Rodrigo Pinheiro Araldi; Hugo Vigerelli; Fernanda D'Ámelio; Thais Biude Mendes; Vivian Gonzaga; Bruna Policíquio; Gabriel Avelar Colozza-Gama; Cristiane Wenceslau Valverde; Irina Kerkis
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 5.  Insights into the Role of Oxidative Stress in Ovarian Cancer.

Authors:  Dan-Ni Ding; Liang-Zhen Xie; Ying Shen; Jia Li; Ying Guo; Yang Fu; Fang-Yuan Liu; Feng-Juan Han
Journal:  Oxid Med Cell Longev       Date:  2021-10-07       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.